Brown S M, Coats D K, Collins M L, Underdahl J P
Department of Ophthalmology and Visual Sciences, Texas Tech University, Lubbock, Texas 79430-7217, USA.
J Cataract Refract Surg. 2001 Nov;27(11):1872-5. doi: 10.1016/s0886-3350(01)01068-9.
We describe a second cluster of cases of iatrogenic strabismus that occurred in clinical practices following cataract surgeries that occurred in 2000 when hyaluronidase was once again unavailable for use in periocular anesthetic regimens. Twelve cases of transient or permanent strabismus were referred by 4 anterior segment surgeons who had no previous cases of postcataract strabismus when performing periocular injections with hyaluronidase. The charts of the patients were reviewed retrospectively. Recurrence of an increase in postoperative strabismus when hyaluronidase became unavailable for a second time supports the concept that this enzyme may be more important than previously suspected in preventing damage to the extraocular muscles after periocular anesthetic injections.
我们描述了第二组医源性斜视病例，这些病例发生在2000年白内障手术后的临床实践中，当时透明质酸酶再次无法用于眼周麻醉方案。4位眼前段外科医生转诊了12例短暂性或永久性斜视病例，这些医生在使用透明质酸酶进行眼周注射时，以前没有白内障术后斜视的病例。对患者的病历进行了回顾性审查。当透明质酸酶再次无法使用时，术后斜视增加的情况再次出现，这支持了这样一种观点，即这种酶在预防眼周麻醉注射后眼外肌损伤方面可能比以前怀疑的更为重要。
